Splash Beverage Group Inc Dossier
Qualitative Analysis
Business overview
Splash Beverage Group, Inc. (NYSE American: SBEV) is a consumer beverage company historically focused on acquiring, developing, and distributing early-stage or undervalued beverage brands. Its legacy portfolio includes brands such as Salt Tequila, Chispo Tequila, and Pulpoloco Sangria. However, due to severe capital constraints, the company's beverage operations have been largely dormant, generating minimal revenue. In response, Splash is executing a strategic pivot (referred to as "Splash 2.0") to transition into a public platform focused on regulated wellness, cannabinoid-based consumer health, and biopharmaceutical products. This transformation is highlighted by strategic investments, such as its CDN$300,000 placement in cannabinoid biopharmaceutical firm Avicanna Inc., and ongoing efforts to acquire operating entities in the cannabinoid space.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
A comprehensive strategic pivot away from the historical beverage business (which suffered from a lack of working capital and unsuccessful commercialization) toward becoming a cannabinoid-based health, wellness, and biopharmaceutical platform company.
Expected impact: Repositioning the company to capture opportunities in the high-growth regulated wellness and cannabinoid sectors, leveraging clinical validation, physician engagement, and healthcare integration.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Provides Splash with exposure to an established, debt-free cannabinoid biopharmaceutical platform with approved products (such as Trunerox for epilepsy), clinical-stage assets, and the MyMedi.ca medical cannabis care platform.
Terms: Splash completed a CDN$300,000 strategic investment in Avicanna's non-brokered private placement on June 9, 2026, acquiring 2,000,000 common shares and 1,000,000 warrants.